Codex DNA Clocks Q3 Sales Growth Of 75%; Acquires Eton Bioscience For $13M
See more from Benzinga
GeoVax Labs In-Licenses Development Rights To Multi-Antigenic COVID-19 Vaccine Candidate
AstraZeneca Plans To Set Up Separate Division For Vaccines & Antibody Therapies - Report
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.